H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)

November 25, 2024 6:54 AM EST Send to a Friend
H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating and $19.00 price target on NRx Pharmaceuticals, Inc. (NASDAQ: NRXP).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login